AVACEN

August 14, 2017August 14, 2017

Avacen Receives CE Mark in EU for Device Designed to Treat Fibromyalgia Pain

News

Avacen Medical recently announced that its product Avacen 100, an over-the-counter (OTC) medical device designed to treat widespread fibromyalgia pain and increase blood circulation, has received CE Marking. The CE Mark means the product meets ... Read more

June 16, 2017June 16, 2017

Avacen and CellMark Team Up to Market Non-Drug Treatment Device for Fibromyalgia Pain

News

San Diego-based biotech company Avacen Medical and CellMark Medical of Gothenburg, Sweden, have formed a strategic partnership to leverage CellMark’s global network across 120 markets to boost sales and marketing of the Avacen-100 Class-II ... Read more

October 19, 2016October 19, 2016

Avacen Medical Supports Simplifying NIH Clinical Trial Reports

News

Avacen Medical announced its strong support for a new initiative by the National Institutes of Health (NIH) to expand and enforce its requirement for clinical trial results to be published on ClinicalTrials.gov. The ... Read more

December 21, 2015December 21, 2015

Fibromyalgia Heat Exchange Therapy Shows Promise

News

Avacen Medical announced promising results from a clinical trial investigating the AVACEN Thermal Exchange System for fibromyalgia treatment, with findings of reduced pain across a widespread index of measures in study participants. The ... Read more